Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs

Technology appraisal guidance
Reference number: TA225
Published: 22 June 2011

TA225 Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab: Appendix A - decision paper presented to the Institute's Guidance Executive

TA225 Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab: Appendix A - decision paper presented to the Institute's Guidance Executive

TA225 Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab: Appendix A - decision paper presented to the Institute's Guidance Executive
16 September 2013
(225.79 Kb 5 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 13 September 2013